Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Decitabine Plus Gemcitabine in Advanced Pancreatic Cancer
NCT02685228Phase 2Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of decitabine in pancreatic cancer (PC), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
decitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02685228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685228.